High-certainty evidence for cervical cancer protection in adolescent girls and young women aged 15 to 26 years.
A study presented at the 2018 ONS Annual Congress explored whether aromatherapy and reflexology can ease anxiety and pain for patients undergoing brachytherapy for cervical cancer.
Researchers compared the efficacy of chemotherapy alone vs concurrent chemoradiotherapy (CCRT) for use after radical hysterectomy among patients with early-stage cervical cancer with risk factors,
A review of the literature on follow-up after positive screening results led researchers to a consensus opinion on timing of diagnostic tests for 4 cancers: breast, cervical, colorectal, and lung.
Comparison of Survival Outcomes Between Radical Hysterectomy and Definitive Radiochemotherapy in Stage IB1 and IIA1 Cervical CancerJanuary 12, 2018
[Cancer Management and Research] A comparison study evaluated whether radical hysterectomy or radiochemotherapy provides superior survival outcomes for patients with stage IB1 or IIA1 cervical cancer.
In an effort to find alternatives to cisplatin as a radiation sensitizer, due to its dose-dependent toxicity and resistance, researchers are exploring food-based options such as blueberry extract.
This fact sheet examines possible links between human papillomaviruses (HPVs) and cancer.
HIV infection may not have a contributory effect on the incidence of invasive cervical cancer (ICC) in women as they age.
Axalimogene filolisbac, an intravenous vaccine currently in clinical trials, could prevent often-fatal cervical cancer relapse.
Fatigue and insomnia can persist for many cervical cancer survivors years after their treatment, and have a serious impact on quality of life.
ASCO offers global recommendations for HPV vaccination tailored to structural resource levels of regions.
Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.
Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.
Nonadherence to NCCN guideline treatment recommendations was strongly associated with decreased survival from early-stage cervical cancer.
The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.
Multidisciplinary team approach reduces cervical cancer treatment delays in Botswana by 50%.
A new study that only included women with a cervix has found the risk of dying from cervical cancer is higher than previously thought.
Despite improved overall survival with standard of care, less than half of patients with locally advanced cervical cancer receive SOC treatment.
HPV DNA testing recommended in all resource settings; HIV should undergo screening more often
Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and CIN3+, which supports an extension of the cervical screening interval beyond five years for some, according to a study.
The vaccine against human papillomavirus (HPV) infection appears even more effective than previously believed and protection appears to occur even when only one or two of the recommended doses are given.
HIV is associated with reduced cancer-specific survival among women with invasive cervical cancer.
Despite confirmation of a link between routine Pap smear screening and a lower risk of developing cervical cancer in women older than 65 years, most US health guidelines discourage older women from undergoing routine Pap smears unless they have pre-existing risk factors.
Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.
Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers.
The addition of a patient navigation component to a population-based IT system boosted screening rates for breast cancer, cervical cancer, and colorectal cancer in patients at high risk for nonadherence.
ASCO has published its first clinical practice guideline on invasive cervical cancer, and the guidelines are the first to offer treatment recommendations tailored to resource availability.
A protein has been identified that can inhibit cellular inflammation, a major contributor to the growth of cervical cancer.
The American Society for Clinical Oncology has developed guidelines for the management and palliative care of women diagnosed with invasive cervical cancer.
Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|